Oncotarget: Hispanic Chronic myelomonocytic leukemia patients
Bioengineer.org,
This Oncotarget study had significantly lower mutation rates in ASXL1 and SETBP1, and a higher rate of muTET2/wtASXL1…
This Oncotarget study had significantly lower mutation rates in ASXL1 and SETBP1, and a higher rate of muTET2/wtASXL1…
Oncotarget published "Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients…